[HTML][HTML] Harnessing CD8+ T cells under HIV antiretroviral therapy

JA Warren, G Clutton, N Goonetilleke - Frontiers in immunology, 2019 - frontiersin.org
Antiretroviral therapy (ART) has transformed HIV from a fatal disease to a chronic condition.
In recent years there has been considerable interest in strategies to enable HIV-infected …

[HTML][HTML] Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy

JA Warren, G Clutton, N Goonetilleke - Frontiers in Immunology, 2019 - frontiersin.org
Antiretroviral therapy (ART) has transformed HIV from a fatal disease to a chronic condition.
In recent years there has been considerable interest in strategies to enable HIV-infected …

Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy

JA Warren, G Clutton… - Frontiers in …, 2019 - pubmed.ncbi.nlm.nih.gov
Antiretroviral therapy (ART) has transformed HIV from a fatal disease to a chronic condition.
In recent years there has been considerable interest in strategies to enable HIV-infected …

[HTML][HTML] Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy

JA Warren, G Clutton, N Goonetilleke - Frontiers in Immunology, 2019 - ncbi.nlm.nih.gov
Antiretroviral therapy (ART) has transformed HIV from a fatal disease to a chronic condition.
In recent years there has been considerable interest in strategies to enable HIV-infected …

[PDF][PDF] Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy

JA Warren, G Clutton… - Front. Immunol. 10: 291 …, 2019 - scienceopen.com
Antiretroviral therapy (ART) has transformed HIV from a fatal disease to a chronic condition.
In recent years there has been considerable interest in strategies to enable HIV-infected …

Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy.

JA Warren, G Clutton, N Goonetilleke - Frontiers in Immunology, 2019 - europepmc.org
Antiretroviral therapy (ART) has transformed HIV from a fatal disease to a chronic condition.
In recent years there has been considerable interest in strategies to enable HIV-infected …